First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 331.66 USD 0.93% Market Closed
Updated: May 25, 2024

Income Statement

Earnings Waterfall
West Pharmaceutical Services Inc

Revenue
2.9B USD
Cost of Revenue
-1.8B USD
Gross Profit
1.1B USD
Operating Expenses
-426.5m USD
Operating Income
661.6m USD
Other Expenses
-92.9m USD
Net Income
568.7m USD

Income Statement
West Pharmaceutical Services Inc

Rotate your device to view
Income Statement
Currency: USD
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
1 376
N/A
1 400
+2%
1 414
+1%
1 421
+1%
1 411
-1%
1 401
-1%
1 390
-1%
1 400
+1%
1 426
+2%
1 454
+2%
1 487
+2%
1 509
+2%
1 535
+2%
1 544
+1%
1 566
+1%
1 599
+2%
1 627
+2%
1 677
+3%
1 711
+2%
1 717
+0%
1 745
+2%
1 767
+1%
1 792
+1%
1 840
+3%
1 888
+3%
1 945
+3%
2 037
+5%
2 147
+5%
2 326
+8%
2 523
+8%
2 681
+6%
2 832
+6%
2 881
+2%
2 929
+2%
2 909
-1%
2 887
-1%
2 884
0%
2 866
-1%
2 927
+2%
2 950
+1%
2 929
-1%
Gross Profit
Cost of Revenue
(946)
(960)
(970)
(974)
(959)
(954)
(944)
(944)
(957)
(970)
(989)
(1 008)
(1 023)
(1 041)
(1 058)
(1 087)
(1 114)
(1 147)
(1 170)
(1 172)
(1 187)
(1 194)
(1 206)
(1 234)
(1 262)
(1 282)
(1 327)
(1 379)
(1 453)
(1 530)
(1 595)
(1 654)
(1 691)
(1 732)
(1 732)
(1 751)
(1 761)
(1 773)
(1 813)
(1 821)
(1 841)
Gross Profit
429
N/A
440
+3%
445
+1%
448
+1%
451
+1%
448
-1%
446
0%
456
+2%
469
+3%
485
+3%
497
+3%
501
+1%
512
+2%
504
-2%
508
+1%
513
+1%
513
+0%
530
+3%
541
+2%
545
+1%
558
+2%
574
+3%
586
+2%
606
+3%
626
+3%
663
+6%
710
+7%
768
+8%
873
+14%
993
+14%
1 086
+9%
1 178
+8%
1 190
+1%
1 197
+1%
1 177
-2%
1 136
-3%
1 123
-1%
1 093
-3%
1 113
+2%
1 129
+1%
1 088
-4%
Operating Income
Operating Expenses
(271)
(269)
(270)
(267)
(263)
(275)
(318)
(327)
(333)
(328)
(283)
(275)
(280)
(278)
(272)
(273)
(278)
(286)
(297)
(295)
(293)
(289)
(294)
(308)
(312)
(323)
(334)
(350)
(363)
(381)
(398)
(421)
(421)
(412)
(390)
(381)
(390)
(399)
(422)
(424)
(427)
Selling, General & Administrative
(232)
(230)
(230)
(229)
(228)
(242)
(240)
(244)
(247)
(238)
(241)
(240)
(243)
(241)
(245)
(243)
(249)
(259)
(262)
(263)
(263)
(264)
(263)
(273)
(276)
(283)
(295)
(302)
(310)
(325)
(341)
(362)
(365)
(354)
(328)
(317)
(320)
(326)
(349)
(353)
(354)
Research & Development
(39)
(39)
(39)
(37)
(35)
(33)
(32)
(34)
(36)
(37)
(37)
(37)
(38)
(39)
(39)
(39)
(38)
(39)
(40)
(40)
(41)
(39)
(39)
(39)
(40)
(41)
(44)
(47)
(48)
(51)
(52)
(53)
(55)
(56)
(56)
(59)
(61)
(63)
(66)
(68)
(69)
Other Operating Expenses
0
0
(1)
(1)
(1)
(0)
(46)
(49)
(51)
(53)
(5)
1
1
2
12
9
10
12
5
8
11
14
8
4
4
2
5
(1)
(4)
(4)
(5)
(6)
(1)
(2)
(6)
(6)
(10)
(10)
(7)
(2)
(4)
Operating Income
159
N/A
171
+8%
175
+2%
181
+4%
188
+4%
172
-8%
128
-26%
129
+0%
136
+6%
157
+15%
214
+36%
226
+6%
232
+3%
226
-3%
236
+5%
240
+2%
235
-2%
244
+4%
243
0%
251
+3%
265
+6%
285
+7%
292
+2%
298
+2%
314
+6%
340
+8%
376
+10%
418
+11%
510
+22%
612
+20%
689
+13%
757
+10%
769
+2%
785
+2%
786
+0%
755
-4%
733
-3%
694
-5%
692
0%
705
+2%
662
-6%
Pre-Tax Income
Interest Income Expense
(15)
(16)
(14)
(12)
(11)
(9)
(13)
(13)
(11)
(10)
(9)
(7)
(7)
(7)
(6)
(7)
(6)
(6)
(6)
(6)
(6)
(6)
(6)
(0)
0
2
0
(5)
(9)
(8)
(7)
(6)
(5)
(6)
(3)
3
5
6
10
8
11
Non-Reccuring Items
0
0
0
0
0
0
0
0
(26)
(24)
(26)
(29)
(4)
(16)
(14)
(11)
(14)
(6)
(8)
(10)
(8)
(7)
(7)
(6)
(5)
(10)
(13)
(12)
(14)
(9)
(4)
(8)
(7)
(5)
(54)
(79)
(88)
(92)
(46)
(15)
(8)
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
5
7
6
5
1
(0)
(1)
(1)
0
1
3
4
5
6
5
4
3
1
0
0
4
(1)
4
Pre-Tax Income
144
N/A
155
+8%
161
+4%
169
+5%
177
+5%
163
-8%
115
-29%
116
+1%
100
-14%
123
+23%
179
+45%
190
+6%
222
+17%
203
-8%
216
+7%
222
+3%
217
-3%
236
+9%
234
-1%
241
+3%
257
+7%
276
+8%
280
+1%
292
+4%
308
+6%
331
+7%
364
+10%
401
+10%
490
+22%
599
+22%
682
+14%
749
+10%
762
+2%
778
+2%
733
-6%
680
-7%
650
-4%
608
-7%
659
+8%
698
+6%
668
-4%
Net Income
Tax Provision
(41)
(45)
(46)
(47)
(50)
(45)
(27)
(26)
(21)
(29)
(50)
(54)
(50)
(36)
(35)
1
(9)
(12)
(6)
(44)
(48)
(57)
(60)
(59)
(58)
(58)
(69)
(73)
(86)
(104)
(95)
(109)
(101)
(112)
(117)
(120)
(116)
(107)
(119)
(122)
(115)
Income from Continuing Operations
102
110
115
122
128
118
88
90
79
95
130
135
172
167
181
223
208
224
228
197
209
219
220
233
251
272
295
329
404
495
587
640
661
666
616
560
534
501
539
576
552
Equity Earnings Affiliates
5
5
5
5
5
5
5
6
6
7
8
8
11
9
9
9
8
9
9
8
7
7
7
9
10
13
17
17
20
23
24
20
22
19
18
21
19
19
18
18
16
Net Income (Common)
108
N/A
115
+7%
119
+4%
127
+7%
133
+5%
123
-7%
94
-24%
96
+2%
85
-11%
102
+20%
138
+35%
144
+4%
182
+27%
176
-3%
190
+8%
151
-21%
133
-11%
151
+13%
155
+3%
207
+34%
219
+6%
229
+5%
230
+0%
242
+5%
261
+8%
286
+10%
312
+9%
346
+11%
423
+22%
519
+23%
613
+18%
662
+8%
684
+3%
686
+0%
631
-8%
586
-7%
552
-6%
519
-6%
559
+8%
593
+6%
569
-4%
EPS (Diluted)
1.48
N/A
1.6
+8%
1.65
+3%
1.75
+6%
1.83
+5%
1.69
-8%
1.28
-24%
1.3
+2%
1.15
-12%
1.37
+19%
1.85
+35%
1.91
+3%
2.43
+27%
2.34
-4%
2.51
+7%
1.98
-21%
1.76
-11%
2
+14%
2.04
+2%
2.74
+34%
2.9
+6%
3.04
+5%
3.04
N/A
3.21
+6%
3.45
+7%
3.78
+10%
4.12
+9%
4.57
+11%
5.58
+22%
6.85
+23%
8.05
+18%
8.66
+8%
9
+4%
9.04
+0%
8.32
-8%
7.72
-7%
7.31
-5%
6.88
-6%
7.42
+8%
7.88
+6%
7.65
-3%

See Also

Discover More